TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303.

Nancy L Bartlett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.